CABA – cabaletta bio, inc. (US:NASDAQ)
Stock Stats
News
Cabaletta Bio, Inc. (NASDAQ: CABA) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $6.00 price target on the stock, down previously from $15.00.
Cabaletta Bio, Inc. (NASDAQ: CABA) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $6.00 price target on the stock, down previously from $12.00.
Cabaletta Bio, Inc.'s (NASDAQ:CABA) latest 25% decline adds to one-year losses, institutional investors may consider drastic measures [Yahoo! Finance]
Cabaletta Bio, Inc. (NASDAQ: CABA) was upgraded by analysts at TD Cowen to a "strong-buy" rating.
Cabaletta Bio to Participate in Upcoming Investor Conferences in December [Yahoo! Finance]
Form SC 13G/A Cabaletta Bio, Inc. Filed by: ALGER ASSOCIATES INC
Form SC 13G/A Cabaletta Bio, Inc. Filed by: PRUDENTIAL FINANCIAL INC
Form SC 13G/A Cabaletta Bio, Inc. Filed by: JENNISON ASSOCIATES LLC
Form 8-K Cabaletta Bio, Inc. For: Nov 18
Form SC 13G/A Cabaletta Bio, Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.